vs
CHEESECAKE FACTORY INC（CAKE）与GENMAB A/S（GMAB）财务数据对比。点击上方公司名可切换其他公司
CHEESECAKE FACTORY INC的季度营收约是GENMAB A/S的1.0倍（$961.6M vs $925.0M），GENMAB A/S净利率更高（36.3% vs 3.0%，领先33.3%），GENMAB A/S同比增速更快（18.7% vs -73.2%）
芝士蛋糕工厂（The Cheesecake Factory）是美国知名的餐饮连锁及芝士蛋糕分销企业，目前在全球运营370家全服务餐厅，其中218家为芝士蛋糕工厂品牌门店，47家为North Italia品牌门店，其余105家为其他品牌门店。此外公司在加利福尼亚州卡拉巴萨斯及北卡罗来纳州落基山城设有两座烘焙生产基地。
Genmab A/S是丹麦生物技术企业，1999年2月由原BankInvest生物医药风险基金董事总经理Florian Schönharting创立，总部位于丹麦哥本哈根，在荷兰乌得勒支、美国新泽西州普林斯顿、日本东京、德国慕尼黑及中国苏州均设有子公司，深耕生物科技领域的研发与运营。
CAKE vs GMAB — 直观对比
营收规模更大
CAKE
是对方的1.0倍
$925.0M
营收增速更快
GMAB
高出91.9%
-73.2%
净利率更高
GMAB
高出33.3%
3.0%
损益表 — Q1 FY2026 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $961.6M | $925.0M |
| 净利润 | $28.8M | $336.0M |
| 毛利率 | — | 93.8% |
| 营业利润率 | 3.5% | 38.9% |
| 净利率 | 3.0% | 36.3% |
| 营收同比 | -73.2% | 18.7% |
| 净利润同比 | -30.1% | 65.5% |
| 每股收益（稀释后） | $0.60 | $5.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CAKEGMAB
| Q1 26 | $961.6M | — | ||
| Q3 25 | $907.2M | — | ||
| Q2 25 | $927.2M | $925.0M | ||
| Q4 24 | $865.5M | — | ||
| Q3 24 | $904.0M | — | ||
| Q2 24 | $891.2M | $779.0M | ||
| Q1 24 | $877.0M | — | ||
| Q4 23 | $830.2M | — |
净利润CAKEGMAB
| Q1 26 | $28.8M | — | ||
| Q3 25 | $31.9M | — | ||
| Q2 25 | $32.9M | $336.0M | ||
| Q4 24 | $30.0M | — | ||
| Q3 24 | $52.4M | — | ||
| Q2 24 | $33.2M | $203.0M | ||
| Q1 24 | $12.7M | — | ||
| Q4 23 | $17.9M | — |
毛利率CAKEGMAB
| Q1 26 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 93.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 96.4% | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
营业利润率CAKEGMAB
| Q1 26 | 3.5% | — | ||
| Q3 25 | 4.1% | — | ||
| Q2 25 | 5.6% | 38.9% | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 6.5% | — | ||
| Q2 24 | 4.4% | 30.3% | ||
| Q1 24 | 0.9% | — | ||
| Q4 23 | 2.3% | — |
净利率CAKEGMAB
| Q1 26 | 3.0% | — | ||
| Q3 25 | 3.5% | — | ||
| Q2 25 | 3.6% | 36.3% | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 3.7% | 26.1% | ||
| Q1 24 | 1.4% | — | ||
| Q4 23 | 2.2% | — |
每股收益（稀释后）CAKEGMAB
| Q1 26 | $0.60 | — | ||
| Q3 25 | $0.66 | — | ||
| Q2 25 | $0.67 | $5.42 | ||
| Q4 24 | $0.61 | — | ||
| Q3 24 | $1.08 | — | ||
| Q2 24 | $0.68 | $3.13 | ||
| Q1 24 | $0.27 | — | ||
| Q4 23 | $0.37 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $215.7M | $1.3B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $5.3B |
| 总资产 | — | $6.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CAKEGMAB
| Q1 26 | $215.7M | — | ||
| Q3 25 | $190.0M | — | ||
| Q2 25 | $135.4M | $1.3B | ||
| Q4 24 | $52.2M | — | ||
| Q3 24 | $40.7M | — | ||
| Q2 24 | $60.2M | $622.0M | ||
| Q1 24 | $56.3M | — | ||
| Q4 23 | $64.0M | — |
股东权益CAKEGMAB
| Q1 26 | — | — | ||
| Q3 25 | $425.3M | — | ||
| Q2 25 | $339.4M | $5.3B | ||
| Q4 24 | $396.4M | — | ||
| Q3 24 | $374.0M | — | ||
| Q2 24 | $332.4M | $4.4B | ||
| Q1 24 | $318.1M | — | ||
| Q4 23 | $321.6M | — |
总资产CAKEGMAB
| Q1 26 | — | — | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $3.1B | $6.5B | ||
| Q4 24 | $2.9B | — | ||
| Q3 24 | $2.9B | — | ||
| Q2 24 | $2.8B | $5.6B | ||
| Q1 24 | $2.8B | — | ||
| Q4 23 | $2.8B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $349.0M |
| 自由现金流经营现金流 - 资本支出 | — | $327.0M |
| 自由现金流率自由现金流/营收 | — | 35.4% |
| 资本支出强度资本支出/营收 | — | 2.4% |
| 现金转化率经营现金流/净利润 | — | 1.04× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CAKEGMAB
| Q1 26 | — | — | ||
| Q3 25 | $147.5M | — | ||
| Q2 25 | $78.9M | $349.0M | ||
| Q4 24 | $79.9M | — | ||
| Q3 24 | $27.7M | — | ||
| Q2 24 | $66.7M | $438.0M | ||
| Q1 24 | $67.9M | — | ||
| Q4 23 | $49.0M | — |
自由现金流CAKEGMAB
| Q1 26 | — | — | ||
| Q3 25 | $69.2M | — | ||
| Q2 25 | $36.1M | $327.0M | ||
| Q4 24 | $25.7M | — | ||
| Q3 24 | $-1.5M | — | ||
| Q2 24 | $29.6M | $430.0M | ||
| Q1 24 | $16.2M | — | ||
| Q4 23 | $11.8M | — |
自由现金流率CAKEGMAB
| Q1 26 | — | — | ||
| Q3 25 | 7.6% | — | ||
| Q2 25 | 3.9% | 35.4% | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | -0.2% | — | ||
| Q2 24 | 3.3% | 55.2% | ||
| Q1 24 | 1.8% | — | ||
| Q4 23 | 1.4% | — |
资本支出强度CAKEGMAB
| Q1 26 | — | — | ||
| Q3 25 | 8.6% | — | ||
| Q2 25 | 4.6% | 2.4% | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 4.2% | 1.0% | ||
| Q1 24 | 5.9% | — | ||
| Q4 23 | 4.5% | — |
现金转化率CAKEGMAB
| Q1 26 | — | — | ||
| Q3 25 | 4.62× | — | ||
| Q2 25 | 2.40× | 1.04× | ||
| Q4 24 | 2.66× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | 2.01× | 2.16× | ||
| Q1 24 | 5.35× | — | ||
| Q4 23 | 2.73× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAKE
暂无分部数据
GMAB
| Darzalex | $638.0M | 69% |
| Kesimpta | $108.0M | 12% |
| Net Product Sales | $101.0M | 11% |
| Other | $28.0M | 3% |
| Tepezza | $20.0M | 2% |
| Reimbursement Revenue | $13.0M | 1% |
| Bio N Tech | $11.0M | 1% |
| Abb Vie | $5.0M | 1% |
| Milestone Revenue | $1.0M | 0% |
